RiceBran (RIBT) Drops in Active Trading for May 13
Equities Staff Follow |Today, RiceBran Technologies (NASDAQ:RIBT) lost $0.03 to end the day Friday at $0.52.
The company started at $0.58 and shares fluctuated between $0.59 and $0.51 with 2,720,909 shares trading hands.
RiceBran is averaging 1,733,208 shares traded over the last 30 days. They have increased 57.59% YTD.
RiceBran anticipates its next earnings on 2022-08-03.
For technical charts, analysis, and more on RiceBran visit the company profile.
About RiceBran Technologies
RiceBran Technologies is a global leader in the production and marketing of value-added products derived from rice bran as well as a producer of rice, rice co-product, and barley and oat products. The target markets for its products include food and animal nutrition manufacturers and retailers, as well as specialty food, functional food and nutritional supplement manufacturers and retailers. Its highly nutritious and clean label ingredient products derived from rice bran, one of the world's most underutilized food sources, are produced utilizing our proprietary stabilization technology.
To get more information on RiceBran Technologies and to follow the company's latest updates, you can visit the company's profile page here: RiceBran Technologies's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.
Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.
Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer